Department of Neurology Home >
- Faculty
| Home |  |
About the Center | |
Faculty Members | |
Patient Care | |
Education and Training | |
Research and Clinical Trials |
Faculty Members:
Kyle M. Kampman, M.D.
Associate Professor of Psychiatry at the Veteran's Administration Medical Center
Medical Director
Department: Psychiatry
Contact information
University of Pennsylvania
Treatment Research Center
3900 Chestnut Street
Philadelphia, PA 19104
Treatment Research Center
3900 Chestnut Street
Philadelphia, PA 19104
Office: (215) 222-3200
Fax: (215) 386-6770
Fax: (215) 386-6770
Email:
kampman_k@mail.trc.upenn.edu
kampman_k@mail.trc.upenn.edu
Education:
B.A. (Chemistry)
Northwestern University, 1981.
MD
Tulane University, 1985.
B.A. (Chemistry)
Northwestern University, 1981.
MD
Tulane University, 1985.
Post-Graduate Training
Intern in Medicine, Naval Hospital, Bethesda, 1985-1986.
Assistant Instructor in Psychiatry, Hospital of the University of Pennsylvania, Philadelphia, 1990-1993.
Fellowship, Addiction Psychiatry, University of Pennsylvania Treatment Research Center, Philadelphia, 1993-1994.
Intern in Medicine, Naval Hospital, Bethesda, 1985-1986.
Assistant Instructor in Psychiatry, Hospital of the University of Pennsylvania, Philadelphia, 1990-1993.
Fellowship, Addiction Psychiatry, University of Pennsylvania Treatment Research Center, Philadelphia, 1993-1994.
Certifications
American Board of Neurology and Psychiatry Certificate in Psychiatry , 1994.
American Board of Neurology and Psychiatry Certificate in Addiction Psychiatry , 1996.
Permanent linkAmerican Board of Neurology and Psychiatry Certificate in Psychiatry , 1994.
American Board of Neurology and Psychiatry Certificate in Addiction Psychiatry , 1996.
Selected Publications
Kampman, K.M., Volpicelli, J.R., Mulvaney, F., Rukstalis, M., Alterman, A.I., Pettinati, H., Weinrieb, R.M., O'Brien, C.P.: Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors 27(2): 251-260, 2002.Kampman, K.M.: Amantadine treatment for cocaine-dependent patients with severe withdrawal symptoms. Expert Review of Neurotherapeutics 2(5): 601-608, 2002.
Kampman, K.M., Pettinati, H., Volpicelli, J., Kaempf, G., Turk, E., Insua, A., Lipkin, C., Sparkman, T., O'Brien, C.P.: Concurrent cocaine withdrawal alters alcohol withdrawal symptoms. Journal of Addictive Diseases 21(4): 13-26, 2002.
Kampman, K.M., Majewska, M.D., Tourian, K., Dackis, C., Cornish, J., Poole, S., O’Brien, C.P.: A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence. Addictive Behaviors 28: 437-448, 2002.
Dackis, C., Kampman, K., Pettinati, H, Weigley, C., O’Brien, C.: An Open-Label Pilot Study of the Effectiveness and Tolerability of Modafinil for Cocaine Dependence. Drug and Alcohol Dependence 66(suppl1): s39-s40, 2002.
Yu, E., Herman, B.H., Miotto, K., Montgomery, A., Fudala, P.J., Chiang, C.J., Fisher, C., Kampman, K., Dhopesh, V., Cornish, J., Walsh, B., Davies, K., Vocci, F., Bridge, P., Ling, W., O’Brien, C.P.: An In-patient Phase I/II Study of Lofexidine (alpha-2 adrenergic agonist) for Opiate Detoxification. Drug and Alcohol Dependence 66(suppl1): s195, 2002.
Kampman, K.M., Alterman, A.I., Volpicelli, J.R., Maany, I., Muller, E.S., Luce, D.L., Mulholland, E.M., Jawad, A.F., Parikh, G.A., Mulvaney, F.D., Weinrieb, R.M., O’Brien, C.P.: Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychology of Addictive Behaviors 15(1): 52-59, 2001.
Kampman, K.M., Volpicelli, J.R., Mulvaney, F., Alterman, A.I., Cornish, J., Gariti, P. Cnaan, A., Poole, S., Muller, E., Acosta, T., Luce, D., O'Brien, C.P.: Effectiveness of propranolol for cocaine dependence may depend on cocaine withdrawal symptom severity. Drug and Alcohol Dependence 63(1): 69-78, 2001.
Kampman KM., Dackis C., Lynch KG., Pettinati H., Tirado C., Gariti P., Sparkman T., Atzram M., O'Brien CP.: A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug & Alcohol Dependence 85(2): 129-37, Nov 8 2006.
Dackis., C., Lynch, K., Yu, E., Samaha, F., Kampman, K., Cornish, J., Rowan, A., Poole, S., White, L., O’Brien, C.: Modafinil and Cocaine: A Double-Blind, Placebo-Controlled Drug Interaction Study. Drug and Alcohol Dependence 70(1): 29-37, 2003.
Comer SD., Sullivan MA., Yu E., Rothenberg JL., Kleber HD., Kampman K., Dackis C., O'Brien CP.: Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Archives of General Psychiatry 63(2): 210-8, Feb 2006.
